| 000 | 01506 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250515190931.0 | ||
| 264 | 0 | _c20100106 | |
| 008 | 201001s 0 0 eng d | ||
| 022 | _a1527-7755 | ||
| 024 | 7 |
_a10.1200/JCO.2009.23.9731 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEve, Heather E | |
| 245 | 0 | 0 |
_aTime to treatment does not influence overall survival in newly diagnosed mantle-cell lymphoma. _h[electronic resource] |
| 260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cNov 2009 |
||
| 300 |
_ae189-90; author reply e191 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, Mantle-Cell _xdrug therapy |
| 650 | 0 | 4 |
_aPrednisolone _xadministration & dosage |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 700 | 1 | _aFurtado, Michelle V | |
| 700 | 1 | _aHamon, Michael D | |
| 700 | 1 | _aRule, Simon A J | |
| 773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 27 _gno. 32 _gp. e189-90; author reply e191 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.2009.23.9731 _zAvailable from publisher's website |
| 999 |
_c19200846 _d19200846 |
||